agilon health Q2 EPS Estimate Reduced by Leerink Partnrs

agilon health, inc. (NYSE:AGLFree Report) – Leerink Partnrs cut their Q2 2025 earnings estimates for agilon health in a research report issued on Wednesday, May 7th. Leerink Partnrs analyst W. Mayo now anticipates that the company will post earnings of ($0.13) per share for the quarter, down from their previous forecast of ($0.09). The consensus estimate for agilon health’s current full-year earnings is ($0.59) per share. Leerink Partnrs also issued estimates for agilon health’s Q3 2025 earnings at ($0.11) EPS, Q4 2025 earnings at ($0.11) EPS, FY2025 earnings at ($0.35) EPS, Q2 2026 earnings at ($0.06) EPS, Q3 2026 earnings at ($0.07) EPS, Q4 2026 earnings at ($0.08) EPS, FY2026 earnings at ($0.20) EPS and FY2027 earnings at ($0.14) EPS.

AGL has been the topic of several other reports. Barclays upped their price target on shares of agilon health from $2.00 to $3.00 and gave the company an “underweight” rating in a report on Thursday. Citigroup raised shares of agilon health from a “neutral” rating to a “buy” rating and upped their price target for the company from $3.25 to $5.00 in a report on Friday, April 25th. Robert W. Baird lowered their target price on shares of agilon health from $6.00 to $5.00 and set a “neutral” rating for the company in a research note on Tuesday, April 15th. The Goldman Sachs Group boosted their target price on shares of agilon health from $2.50 to $5.00 and gave the company a “neutral” rating in a research note on Thursday. Finally, Stifel Nicolaus boosted their target price on shares of agilon health from $2.00 to $3.00 and gave the company a “hold” rating in a research note on Wednesday, February 26th. Two investment analysts have rated the stock with a sell rating, thirteen have given a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, agilon health has an average rating of “Hold” and an average target price of $4.89.

Check Out Our Latest Stock Report on AGL

agilon health Trading Down 10.9%

AGL opened at $2.87 on Monday. The stock has a market capitalization of $1.19 billion, a PE ratio of -3.05 and a beta of 0.38. The firm’s fifty day moving average price is $4.27 and its 200 day moving average price is $3.19. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. agilon health has a 12-month low of $1.50 and a 12-month high of $7.73.

agilon health (NYSE:AGLGet Free Report) last posted its earnings results on Tuesday, May 6th. The company reported $0.03 EPS for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.04. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The business had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.50 billion. During the same period in the previous year, the company posted ($0.02) earnings per share. The business’s revenue for the quarter was down 4.5% compared to the same quarter last year.

Hedge Funds Weigh In On agilon health

A number of institutional investors and hedge funds have recently bought and sold shares of AGL. Barclays PLC boosted its position in shares of agilon health by 21.2% during the 3rd quarter. Barclays PLC now owns 1,228,952 shares of the company’s stock valued at $4,830,000 after purchasing an additional 214,830 shares in the last quarter. JPMorgan Chase & Co. boosted its position in shares of agilon health by 326.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock valued at $5,563,000 after purchasing an additional 1,083,492 shares in the last quarter. Pines Wealth Management LLC purchased a new stake in agilon health during the fourth quarter valued at about $51,000. Oak Thistle LLC purchased a new stake in agilon health during the fourth quarter valued at about $25,000. Finally, Inspire Investing LLC lifted its stake in agilon health by 106.6% during the fourth quarter. Inspire Investing LLC now owns 217,550 shares of the company’s stock valued at $413,000 after buying an additional 112,241 shares in the last quarter.

agilon health Company Profile

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

See Also

Earnings History and Estimates for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.